This week, researchers develop an eye-on-a-chip model for dry eye disease, aflibercept sales continue to impress and a new documentary follows 4 artists who have partial or complete blindness. Source: AAO
This study evaluated the outcomes of unilateral cataract surgery in children ranging from 7 to 24 months of age. Source: AAO
In this prospective analysis, researchers assessed perfused capillary density (PCD) in diabetic and healthy patients using OCT imaging. Source: AAO
This animal study assessed the effectiveness of retrobulbar hyaluronidase treatment for blindness resulting from soft-tissue filler injection. Source: AAO
This study compared corneal higher-order aberrations after ultrathin Descemet stripping automated endothelial keratoplasty (DSAEK) versus Descemet membrane endothelial keratoplasty (DMEK). Source: AAO
Researchers measured corneal thickness changes with isotonic riboflavin solution and hydroxypropyl methylcellulose during accelerated corneal collagen crosslinking (CXL) with or without the use of an eyelid speculum. Source: AAO
This week, Pixium’s bionic vision system restores sight to patients with advanced AMD, a brain tumor lingers behind a woman’s red, itchy eyes and Bascom Palmer Eye Institute tops the Best Hospitals for Ophthalmology survey for the 14th year in a row. Source: AAO
In this retrospective analysis, investigators identified retinal nonperfusion characteristics that led to the development of proliferative diabetic retinopathy (PDR). Source: AAO
Editas Medicine and Allergan are teaming up to conduct the first human trial of a CRISPR gene-editing therapy for inherited blindness. Source: AAO
The authors describe a new technique called transzonular capsulo-hyaloidal hydroseparation to detect or induce anterior hyaloid membrane detachment for primary posterior laser capsulotomy. Source: AAO